Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Omer Abdul Hamid

Neurology with Special Qualifications in Child Neurology Orlando, FL Medical Doctor

NPI 1780048397 CMS profile 9378335

6535 Nemours Pkwy, Orlando, FL 32827

Open in the dashboard

General payments

$282,506

287 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$184,983 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Omer Abdul Hamid of Orlando, FL is reported in the CMS Open Payments database as having received $282,506 across 287 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $184,983 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $71,121 74
2024 General $75,056 107
2023 General $45,742 93
2022 General $556 10
2021 General $90,030 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Omer Abdul Hamid
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Omer Abdul Hamid were reported at $71,121. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Omer Abdul Hamid Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $0 $262 $68–$1,313 $163
2020 $0 $188 $46–$1,222 $114
2021 $90,030 $183 $45–$1,356 $132
2022 $556 $229 $72–$1,177 $149
2023 $45,742 $269 $93–$1,195 $160
2024 $75,056 $300 $98–$1,428 $164
2025 $71,121 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Biogen, Inc. $124,912 59 payments
  2. Genentech USA, Inc. $73,112 67 payments
  3. Sarepta Therapeutics, Inc. $52,939 67 payments
  4. Catalyst Pharmaceuticals, Inc. $11,268 18 payments
  5. ITF Therapeutics LLC $6,138 9 payments
  6. PTC Therapeutics, Inc. $4,808 2 payments
  7. Pfizer Inc. $3,823 3 payments
  8. UCB, Inc. $2,043 7 payments
  9. Genentech, Inc. $1,022 14 payments
  10. LivaNova USA, Inc. $761 4 payments
  11. Other $1,682 37 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $90,000 1 payment
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $82,331 33 payments
  3. Consulting Fee $70,027 18 payments
  4. Travel and Lodging $19,165 50 payments
  5. Food and Beverage $11,230 181 payments
  6. Honoraria $9,753 4 payments
Products named General payments · program years 2021–2025
  1. Evrysdi $74,130 80 payments
  2. Elevidys $35,632 38 payments
  3. Skyclarys $21,666 17 payments
  4. SPINRAZA $14,519 42 payments
  5. AGAMREE $11,148 14 payments
  6. Zurzuvae $2,421 1 payment
  7. VNS Therapy $733 3 payments
  8. DAYBUE $360 7 payments
  9. VILTEPSO $326 9 payments
  10. ZTALMY $255 3 payments
  11. Other $970 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

287 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record